Prescribing information can be found at the bottom of the page

Renal Outcomes

Invokana reduces protein in the urine and the risk of Major Adverse Renal Events (MARE)…

…while stabilising eGFR levels for the long term.

With standard of care, eGFR declines over time. After an initial fall in mean eGFR during the first 4 weeks of treatment, Invokana stabilises eGFR levels for the long term. 1

Improvements in renal outcomes with Invokana are additional benefits only and not licensed indications.
References
  1. Neal B, et al. N Engl J Med. 2017;377(7):644-57
  2. Perkovic V, et al. Lancet Diabetes Endocrinol 2018;6(9):691-704